These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 6531440)

  • 1. Effect of apomorphine, a dopamine receptor agonist, on penile tumescence in normal subjects.
    Lal S; Ackman D; Thavundayil JX; Kiely ME; Etienne P
    Prog Neuropsychopharmacol Biol Psychiatry; 1984; 8(4-6):695-9. PubMed ID: 6531440
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Apomorphine-induced penile tumescence in impotent patients--preliminary findings.
    Lal S; Laryea E; Thavundayil JX; Nair NP; Negrete J; Ackman D; Blundell P; Gardiner RJ
    Prog Neuropsychopharmacol Biol Psychiatry; 1987; 11(2-3):235-42. PubMed ID: 3628831
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apomorphine: clinical studies on erectile impotence and yawning.
    Lal S; Tesfaye Y; Thavundayil JX; Thompson TR; Kiely ME; Nair NP; Grassino A; Dubrovsky B
    Prog Neuropsychopharmacol Biol Psychiatry; 1989; 13(3-4):329-39. PubMed ID: 2748870
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of blood sampling on apomorphine-induced penile tumescence in erectile impotence: a case report.
    Kiely ME; Thavundayil JX; Lal S
    J Psychiatry Neurosci; 1995 May; 20(3):233-5. PubMed ID: 7786885
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apomorphine in the evaluation of dopaminergic function in man.
    Lal S
    Prog Neuropsychopharmacol Biol Psychiatry; 1988; 12(2-3):117-64. PubMed ID: 3290992
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of intracranial administration of the dopamine agonist apomorphine on penile reflexes and seminal emission in the rat.
    Pehek EA; Thompson JT; Hull EM
    Brain Res; 1989 Oct; 500(1-2):325-32. PubMed ID: 2605500
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A simple method for the study of yawning in man induced by the dopamine receptor agonist, apomorphine.
    Lal S; Grassino A; Thavundayil JX; Dubrovsky B
    Prog Neuropsychopharmacol Biol Psychiatry; 1987; 11(2-3):223-8. PubMed ID: 3628829
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interactions between endogenous dopamine and dopamine agonists at release modulatory receptors: multiple effects of neuronal uptake inhibitors on transmitter release.
    Hoffmann IS; Talmaciu RK; Cubeddu LX
    J Pharmacol Exp Ther; 1986 Aug; 238(2):437-46. PubMed ID: 2942676
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CCK-8 antagonizes apomorphine-induced growth hormone secretion in normal subjects.
    Nair NP; Lal S; Eugenio H; Lizondo E; Thavundayil JX; Wood PL; Etienne P; Guyda H
    Horm Metab Res; 1986 Jan; 18(1):53-5. PubMed ID: 3949282
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of apomorphine on penile tumescence in men with psychogenic impotence.
    Segraves RT; Bari M; Segraves K; Spirnak P
    J Urol; 1991 Jun; 145(6):1174-5. PubMed ID: 2033687
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined administration of direct dopamine receptor agonists and L-dopa does not interfere with utilization of exogenous L-dopa in rat corpus striatum.
    Globus M; Melamed E
    Prog Neuropsychopharmacol Biol Psychiatry; 1983; 7(2-3):211-5. PubMed ID: 6310691
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Penile erection induced by apomorphine and N-n-propyl-norapomorphine in rats.
    Benassi-Benelli A; Ferrari F; Quarantotti BP
    Arch Int Pharmacodyn Ther; 1979 Dec; 242(2):241-7. PubMed ID: 44457
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of apomorphine on melatonin secretion in normal subjects.
    Lal S; Isaac I; Pilapil C; Nair NP; Hariharasubramanian N; Guyda H; Quirion R
    Prog Neuropsychopharmacol Biol Psychiatry; 1987; 11(2-3):229-33. PubMed ID: 3628830
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 5-HT(2C) receptor activation is a common mechanism on proerectile effects of apomorphine, oxytocin and melanotan-II in rats.
    Kimura Y; Naitou Y; Wanibuchi F; Yamaguchi T
    Eur J Pharmacol; 2008 Jul; 589(1-3):157-62. PubMed ID: 18582863
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of L-DOPA on nigral dopamine neurons and local field potential: comparison with apomorphine and muscimol.
    Xu D; Karain B; Brantley E; Shi WX
    J Pharmacol Exp Ther; 2011 May; 337(2):533-9. PubMed ID: 21330359
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of tolerance of dopaminergic responses in man.
    Lal S; Thavundayil JX; Ng Ying Kin NM; Dai X; Schwartz G; Montoya A
    J Neural Transm (Vienna); 2008 Aug; 115(8):1189-98. PubMed ID: 18506387
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of spontaneous and dopaminergic-induced yawning and penile erections in the rat.
    Holmgren B; Urbá-Holmgren R; Trucios N; Zermeño M; Eguíbar JR
    Pharmacol Biochem Behav; 1985 Jan; 22(1):31-5. PubMed ID: 3975244
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of chronic bromocriptine and L-dopa on spiperone binding and apomorphine-induced stereotypy.
    Globus M; Bannet J; Lerer B; Belmaker RH
    Psychopharmacology (Berl); 1982; 78(1):81-4. PubMed ID: 6815701
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dopamine agonists at repeated "autoreceptor-selective" doses: effects upon the sensitivity of A10 dopamine autoreceptors.
    Jeziorski M; White FJ
    Synapse; 1989; 4(4):267-80. PubMed ID: 2603146
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of SR 48692, a selective non-peptide neurotensin receptor antagonist, on two dopamine-dependent behavioural responses in mice and rats.
    Poncelet M; Souilhac J; Gueudet C; Terranova JP; Gully D; Le Fur G; Soubrié P
    Psychopharmacology (Berl); 1994 Oct; 116(2):237-41. PubMed ID: 7862953
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.